Clinical trial
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
NCT00496483 · Veloxis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00496483 |
|---|---|
| Title | Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients |
| Official title | A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Kidney Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf® Capsules Twice-A-Day |
| Lead sponsor | Veloxis Pharmaceuticals, Industry |
| Collaborators | CTI Clinical Trial and Consulting Services |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Failure |
| Intervention type | Drug |
| Interventions | LCP Tacro (tacrolimus), Prograf |
| Enrollment | 60 |
| Start date | Jul 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jul 4, 2007 |
| Last update posted | Jul 23, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: